Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 21, 2019Clinical Lymphoma Myeloma & LeukemiaOpen Access

Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAnthony R. MatoMemorial Sloan Kettering Cancer CenterJBJacqueline C. BarrientosHofstra UniversityNGNilanjan GhoshLevine Cancer Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mato et al. (2019) studied this question.

synapsesocial.com/papers/6a842390da9d2319e77bf3eahttps://doi.org/10.1016/j.clml.2019.10.009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.20152015 · 78 citations
  2. 2Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia2000 · 3,325 citations
  3. 3Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia2019 · 751 citations
  4. 4Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL2017 · 239 citations
  5. 5Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia2014 · 281 citations